News
Morgan Stanley analyst Terence Flynn notes that Pfizer (PFE) announced that after a review of the totality of the data for its pipeline oral ...
People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.
A new clinical trial led by researchers at the University of North Carolina School of Medicine has revealed that the oral form of semaglutide (GLP-1) significantly reduces the risk of heart ...
By Gary Trust ROSÉ and Bruno Mars’ “APT.” adds a record-extending 19th week at No. 1 on the Billboard Global Excl. U.S. chart. The collaboration first moved into the top floor in November.
The result is "consistent with prior studies of injectable semaglutide and other GLP-1 receptor agonist," but a positive result is still a big deal, said principal investigator Darren K.
The first four episodes of Call Jonathan Pie series 2 are now available on BBC Sounds, subscribe to be alerted when new episodes in the series are released. Frustrated call-show host Jonathan Pie ...
Combining these three picks into an MLB parlay would result in a payout of nearly 6-1. The model simulates every game 10,000 times and is on a 32-17 roll on all top-rated MLB picks on the run ...
The OBR halved its forecast for economic growth in UK in 2025, saying it now expected gross domestic product to grow by 1% this year. That's down from a previous forecast, released in October, of 2% ...
Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient ...
That these treatments are helping people curb their eating should be no surprise: that is exactly what they are meant to do, by mimicking the satiety hormone GLP-1 (see “How they work”, below).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback